Ameriprise’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Ameriprise's BCAT Position: Q1 2026 in Review
Ameriprise reduced its BlackRock Capital Allocation Term Trust (BCAT) stake by 0.27% in Q1 2026, selling an estimated $4.85K and leaving 120,460 shares worth $1.7M. The position accounts for ﹤0.01% of the portfolio, ranked #3031.
Ameriprise first reported a position in BCAT in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.73M in Q2 2025. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.
- Ameriprise held 120,460 shares of BlackRock Capital Allocation Term Trust worth $1.7M as of Q1 2026.
- Ameriprise sold 329 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $4.85K.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3031 holding.
- Ameriprise first reported a position in BlackRock Capital Allocation Term Trust in Q2 2021 and has held it in 20 quarters since.
- Ameriprise's BlackRock Capital Allocation Term Trust position peaked at $1.73M in Q2 2025.
- 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.